Volpara Solutions, a Wellington-based Healthcare Technology organization has announced the appointment of Katherine Singson as CEO. In her role, Katherine will be responsible for driving continued growth for Volpara’s breast cancer detection and patient tracking software.
Katherine is a veteran with more then 30+ years of experience in the industry. She has worked for start-ups as well as multinational organizations, which includes NeXT/Apple, Pixar and Microsoft. With such experience, Katherine brings both business-to-business as well as direct-to-consumer experience to this crucial new role. After being mentored by Steve Jobs at all three of his companies, she spent several years abroad including in Sydney, Australia. A highlight of this time overseas was working at Microsoft ANZ (Australia & New Zealand) where she partnered with Oprah Winfrey’s Ultimate Australian Adventure to showcase both Windows and Xbox in a deeply humanistic manner. Katherine is also a recent breast cancer survivor.
“As a purpose-driven technology company with the potential to transform the future of breast cancer, we’re excited to have someone of Katherine’s experience unleash our potential,” says Dr. Ralph Highnam, Founder & New Zealand-based Group CEO. He further adds “Volpara is already working with luminary customers across the US, including renowned sites in New York, Houston, San Francisco, Austin, Charlotte and Seattle, and of course, we want to reach many more. We look forward to Katherine positively impacting the healthcare industry and seeing how she’ll no doubt tap into the power and passion of women to obliterate advanced-stage breast cancer”.
“In these uncertain times, we aim to create a nimble, responsive and tastefully relentless approach to addressing this destructive disease,” says Katherine. “Since Covid-19, the idea of actively participating in one’s own self-care in partnership with leading-edge healthcare providers is stronger than ever,” she adds.
About Volpara:
Volpara is a health tech company that is committed to help save lives of people from cancer. Volpara combines artificial intelligence, physics and data to measure breast density for early detection of cancer as well as the clinical management of images. Nearly half of women in the US have dense breast tissue. Objective breast density analysis can help clinicians and their patients create a plan for ongoing screening based on each woman’s individual risk factors. Additionally, Volpara’s software provides quality control for mammography centers and patient tracking software.
